China is returning to normal after disruptions earlier this year, such as the Covid pandemic, the local head of Singapore’s largest personal healthcare provider said on Saturday at the 3rd Forbes China Healthcare Summit.
“Covid has presented us with a lot of operational challenges,” said Dr. Vincent Chia, managing director of Raffles China Healthcare, a subsidiary of Raffles Medical Group in Singapore. “Things seem a little more relaxed, but in a very coordinated way. “he said.
Raffles Medical Group has been operating in China for 2010. It supplies healthcare in 8 cities in addition to Hong Kong. That’s more than part of the existing total of 14 in Asia.
This year, Raffles China Healthcare will open an in vitro fertilization/assisted replication treatment center in Hainan, dubbed “China Hawaii. “Said.
Speaking at a panel on “Fighting Cancer Through International Institutional Collaboration,” Chia said the key to good fortune in China is working well with local regulators and keeping in mind that it is still a newcomer there, even if it is well established in China. home.
“We face a multitude of very different regulatory challenges,” he said. “You have to know how to have interaction and navigate in 14 cities and other governments. “
“There are policies and regulations and controls that are pan-Chinese,” Chia said. “But in each and every community and in every city, it’s very different. “
“We want to have interaction and, in China itself, it’s a matter of adaptation and navigation, and it’s a matter of compromise. It’s a matter of understanding the culture,” he said. It’s about integrating rather than integrating. “with us. It is helping us a lot, however, we are well informed.
Investing in the country requires “first a lot of homework and then, after that, coming in with an open brain at the same time to participate” and addressing local considerations about security and security protocols, Chia said. vital person” of his team in China, he said, is the head of government relations.
Raffles Medical Group has its roots in 1976. It is indexed on the Singapore Stock Exchange and employs over 2500 people.
Although we know him well, he is still a newcomer to China. “We are bringing a foreign logo from Singapore to China, and we are emerging into demanding situations as we visit local communities” and vice versa. Chia said: “China has a population of 1. 4 billion. We have a very small organization and we just have to do everything we can for the local communities in China itself,” he said.
In addition to in-person physical care services, Raffles strives to offer online materials, add consultations, and referrals. It also sees space to offer education, forums or, either online after the total disappearance of Covid, offline. Medical education, nursing education, institutional exchanges on quality and protection criteria will also be offering perspectives, Chia said.
Raffle’s presence in Hainan, a flexible industrial zone, would possibly give it room for maneuver that is nowhere else in China. experiment with new technologies and treatments,” he said.
Other speakers at the summit included: Steve Forbes, president and editor-in-chief of Forbes; Dr. Lisa DeAngelis, Chief of Staff, Memorial Sloan Kettering Cancer Center; Hon. Kevin Rudd, President and CEO of Asia Society, Prime Minister of Australia; Dr. Wu Yi-Long, Chairman of the China Thoracic Oncology Group; Greg Simon, Inaugural Executive Director, White House Cancer Moonshot; Dr. Nancy Y. Lee, Chief and Vice President, Radiation Oncology, MSK; Dr. Bob T. Li, Medical Ambassador to China and Asia-Pacific, MSK; Dr. Louis J. DeGennaro, president and CEO of the Leukemia and Lymphoma Society;
In addition, Dr. Tyler Jacks, president of Break Through Cancer; Professor Andrew W. Lo, Professor of Finance, MIT; Kenneth Manotti, Senior Vice President and Chief Development Officer, MSK; Dr. Yinghua Wang, Senior Project Manager for Regulatory Health, Center of Excellence in Oncology, FDA; Rose Gao, Head of Global Drug Development at Novartis in China, Novartis; Dr. Eduard Gasal, President of Innovent USA; and Dr. Yibing Shan, Executive Director of the Antidote Foundation for the Cure of Cancer; and I spoke.
See similar articles:
US Cancer Moonshot Desires Greater Foreign Efforts to Achieve Truly Extensive Progress – Kevin Rudd
From Patient to Political Member: Greg Simon’s Cancer Treatment Includes Call for Better Biden Rally
Meet the scientist who is President Biden’s new Moonshot cancer
“Why is cancer less to heal faster than covid?”: Cancer Moonshot Pathways
Social Justice, Outreach, Global Collaboration: Cancer Moonshot Pathways
Break down barriers to getting things done: Cancer Moonshot Pathways
Biden Deserves to Be Identified for Tackling Cancer: Cancer Moonshot Pathways
@rfannerychina